GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Change In Receivables

Star Lake Bioscience Co (SHSE:600866) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Change In Receivables?

Star Lake Bioscience Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Star Lake Bioscience Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Star Lake Bioscience Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥83 Mil. It means Star Lake Bioscience Co's Accounts Receivable declined by ¥83 Mil from Dec. 2022 to Dec. 2023 .

Star Lake Bioscience Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥833 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Star Lake Bioscience Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 18.09.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Star Lake Bioscience Co's liquidation value for the three months ended in Mar. 2024 was ¥-3,699 Mil.

Star Lake Bioscience Co Change In Receivables Historical Data

The historical data trend for Star Lake Bioscience Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Change In Receivables Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -53.52 -23.30 112.79 296.40 82.68

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Star Lake Bioscience Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Lake Bioscience Co  (SHSE:600866) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Star Lake Bioscience Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=832.628/4199.501*91
=18.09

2. In Ben Graham's calculation of liquidation value, Star Lake Bioscience Co's accounts receivable are only considered to be worth 75% of book value:

Star Lake Bioscience Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1054.777-6751.988+0.75 * 832.628+0.5 * 2747.932
=-3,699

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Star Lake Bioscience Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Change In Receivables
Comparable Companies
SZSE:300841 SHSE:688526 SZSE:002275 SZSE:301047 SZSE:000990 SHSE:600645 SHSE:600200 SHSE:688197 SHSE:600201 SHSE:605116 OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Website
http://www.starlake.com.cn
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines